| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




From the * Andrology Unit, Department of Clinical
Physiopathology, Diabetes Section;
Geriatric
Unit, Department of Critical Care;
Psychiatry
Unit, Department of Neurological and Psychiatric Sciences, University of
Florence, Florence, Italy; and the
Endocrinology Unit, Maggiore-Bellaria
Hospital, Bologna, Italy.
| Correspondence to: Prof Mario Maggi, Andrology Unit, Department of Clinical Physiopathology, Viale Pieraccini 6, 50139 Florence, Italy (e-mail: m.maggi{at}dfc.unifi.it). |
| Received for publication May 10, 2006; accepted for publication June 21, 2006. |
| Abstract |
|---|
|
|
|---|
Key words: Erectile dysfunction, SIEDY, structured interview, delayed ejaculation, hypoactive sexual desire, couple sexual dysfunction
| Introduction |
|---|
|
|
|---|
Any sexual dysfunction originating from either of the couple's members may became shortly thereafter a disorder that affects the entire couple. In other words, sexual dysfunction in one member of the couple may induce a marked distress in the relative partner, which in turn can generate partner avoidance and antipathy, further exacerbating the original difficulties and leading to an overt couple sexual dysfunction (Althof et al, 2005). Since the early 1970s it has been suggested that female partners of men with sexual dysfunction have significantly lower sex drives than other women (Master and Johnson, 1970, Derogatis et al, 1977). More recently studies from Sweden and Israel showed that women reporting sexual dysfunction were often partners of men with erectile problems (Oberg et al, 2004; Greenstein et al, 2006). Female partners of men with erectile dysfunction (ED) after radical prostatectomy and altered International Index of Erectile Function have a significantly associated altered Female Sexual Function Index (Shindel et al, 2005). Accordingly, treating ED in the male with a phosphodiesterase type 5 inhibitor, vardenafil, improved female sexual quality of life and overall couple well-being (Fisher et al, 2005, Goldstein et al, 2005).
To date it is not clear to what extent a clinical, or even a subclinical,
sexual dysfunction in the female partner might be associated with ED in the
male partner. It is conceivable that impaired sexual fitness in the female
partner (eg, dry vagina) might precipitate a subclinical erectile problem
leading to an overt couple sexual dysfunction. Accordingly, in a series of men
presenting with ED in which their partners were also examined, clinical
evidence of urogenital atrophy was found in 33.3% of women
(Riley and Riley,
2000).
|
The present study is aimed at the assessment of clinical features of ED associated with relational disturbances. The relational component of male sexual dysfunction was explored using the Structured Interview on Erectile Dysfunction (SIEDY) (Petrone et al, 2003; Corona et al, 2006a [review]). SIEDY is an easy to administer instrument for the first screening of ED patients, providing scores for the relational, organic, and intrapsychic components.
| Patients and Methods |
|---|
|
|
|---|
The patients enrolled underwent the usual diagnostic protocol applied to newly referred subjects at the andrology outpatient clinic. All the data provided were collected as part of the routine clinical procedure. Patients were interviewed prior to the beginning of any treatment and before any specific diagnostic procedures using the SIEDY (Petrone et al, 2003). This is a 13-item interview, previously validated, composed of 3 scales that identify and quantify components related to ED. Scale 1 deals with organic disorders, Scale 2 with disturbances in relationship with partner, and Scale 3 with psychologic traits (Petrone et al, 2003). SIEDY Scale 2 questions are reported in Appendix A. They essentially include questions on the presence of partner's diseases impairing her sexual response, the presence of menopausal symptoms, and the partner's inability to achieve climax and express sexual interest.
The characteristics of ED were assessed using SIEDY Appendix A as
previously described (Petrone et al,
2003). In particular, severe ED was defined when patients reported
erections sufficient for penetration in less than 25% of occasions. Hypoactive
sexual desire (HSD) was assessed with question #14 of SIEDY as previously
described (Corona et al, 2004a;
Corona et al, 2005). Premature
ejaculation (PE) was defined as ejaculation within 1 minute of vaginal
intromission (as reported by the patient) according to previously described
criteria (Corona et al, 2004b;
Jannini and Lenzi, 2005).
Delayed ejaculation (DE) was defined as "slowness to ejaculate"
(as reported by the patient) according to previously described criteria
(Corona et al, 2006b). The
severity of DE was categorized on a 3-point scale using a standard question,
"In the last three months is it difficult to ejaculate during sexual
intercourse?", and rating 0 (no DE), 1 (mild/moderate DE [MMDE]), or 2
(anejaculation/severe DE). The presence of extramarital affairs was evaluated
using question #12 of SIEDY. Men were defined as alcohol abusers when they
reported more than 4 drinks per day. Relationship span was assessed using a
specific question, "How long is the relationship with your
partner?", and rating 0 (<1 year), 1 (1 to 5 years), 2 (6 to 10
years), or 3 (>10 years). Frequency of sexual intercourse was investigated
using a standard question, "During the last three months how many sexual
attempts per month did you have?", and rating 0 (no attempts), 1 (1 to 2
attempts), 2 (3 to 7 attempts), or 3 (
8 attempts).
Patients were asked to specify any current pharmacologic treatment for any reason (including infertility); drugs listed in Broderick and Foremann (1999) were considered capable of interfering with sexual function. Patients were asked to complete the Middlesex Hospital Questionnaire, modified (MHQ) (Crown and Crisp, 1966), in the Italian version (Dioguardi et al, 1984), a brief self-reported questionnaire for the screening of mental disorders in a nonpsychiatric setting, which provides scores for free-floating anxiety (MHQ-A), phobic anxiety (MHQ-F), obsessive-compulsive traits and symptoms (MHQ-O), somatization (MHQ-S), depressive symptoms (MHQ-D), and hysteric traits and symptoms (MHQ-H).
All patients underwent a complete physical and andrologic examination, with measurement of blood pressure (mean of 3 measurements 5 minutes apart, in a sitting position, with a standard sphygmomanometer), height, weight, and testis volume (Prader orchidometer). Blood samples were drawn in the morning, after an overnight fast, for determination of blood glucose (by a glucose oxidase method; Aeroset Abbott, Rome, Italy); total cholesterol, high-density lipoprotein cholesterol, and triglycerides (by an automated enzymatic colorimetric method; Aeroset Abbott); total testosterone, prolactin, follicle-stimulating hormone, luteinizing hormone, thyroid-stimulating hormone, and prostate-specific antigen (by an electrochemiluminescent method; Modular Roche, Milan, Italy). Penile Doppler ultrasound examination was performed as previously described (Mancini et al, 2000).
|
| Results |
|---|
|
|
|---|
SIEDY Scale 2 score significantly (P < .0001 at ANOVA) increased as a function of patient and partner ages. At multivariate regression analysis, only partner's age was significantly associated with the SIEDY Scale 2 score (Adj. r = .270; P < .0001; see Figure 2A). No difference in SIEDY Scale 2 score was observed between patients with stable relationships living or not living together (data not shown). Patients reporting a relationship span longer than 10 years (Figure 2B), as well as those with the presence of any degree of relationship conflict (Figure 2C) showed higher SIEDY Scale 2 scores than the rest of the sample. SIEDY Scale 2 score was significantly higher in patients reporting a higher prevalence of stable extramarital affairs, when compared with the rest of the sample (Figure 2D). Moreover, SIEDY Scale 2 scores were significantly higher in patients reporting a higher prevalence of alcohol abuse (2.94 ± 2.45 vs 1.90 ± 2.06; P < .0001). All these differences were confirmed at multivariate analysis after adjustment for partner's age (data not shown).
|
|
|
| Discussion |
|---|
|
|
|---|
SIEDY Scale 2 score is tightly associated with partner's age and relationship duration. In couple relationships lasting more than 10 years, a sudden increase in Scale 2 score was observed. Interestingly, this association retains significance even after correction for confounding factors such as patient's and partner's chronologic ages. This finding is in good agreement with the speculation that humans are not strictly monogamous but can be included in the category of polygamous primates with a special kind of partnership, called "serial monogamy" by Potts and Short (1999). Interestingly, when extramarital affairs are not occasional, Scale 2 score significantly rises. In fact, it can be speculated that conflicts between partners can sometimes increase over time, possibly leading to interruption of the relationship. When cultural and/or religion factors represent an obstacle for divorce, conflicts can became unbearable in some couples with long-lasting relationships. Accordingly, men of couples with extramarital affairs reported less enjoyment in time spent together, more steps taken toward separation and divorce, and problems with trust and dishonesty and, more importantly, more sexual dissatisfaction and alcohol abuse (Atkins et al, 2005). Hence, both prolonged monogamy and stable polygamy are associated with an impaired quality of relationship, as measured by Scale 2, and might be involved in the pathogenesis of ED. An increase in Scale 2 score is associated also with any kind of intracouple hostility, alcohol abuse, and depressive symptoms. Obviously, interpersonal problems, such as sexual problems, may be the cause or the result of dysfunctional or unsatisfactory relationships (Althof et al, 2005). Although a causal relationship between relational determinants of ED and the presence of a long, hostile, and most probably dissatisfying couple bounding cannot be drawn, it is interesting to note that negative feelings and behaviors, as depressed mood and alcohol abuse, are associated with them. A decrease in patient's sexual desire and intercourse frequency can be viewed as the obvious result of elevated SIEDY Scale 2 score, but again the reverse should also be considered. Finally, the previously described association between MMDE and SIEDY Scale 2 score is confirmed in this study (Corona et al, 2006b).
In this paper, data on female sexual fitness are not directly derived from female interviews but from the male reports. Although this is an obvious bias, patient's perception of partner sexual performance closely represents the setting in which the couple is interacting and therefore where the dysfunction is originating, at least as perceived by the patient (Corona et al, 2005). In fact, men with ED and their female partners appear to overestimate the importance their respective partners put on sexual intercourse. Although only 20.2% of women considered sexual intercourse to be somewhat or very important to them, 47.6% of their male partners considered this to be the case (Riley and Riley, 2000).
It should be recognized that these results are derived from patients consulting an Italian andrologic clinic for sexual dysfunction; these patients may have different characteristics than those consulting general practitioners or not seeking medical care. In particular, Lau (2006) recently reported that in rural China women's lack of interest in sex or inability to achieve climax did not predict any male partner sexual dysfunction. The same authors suggested the possible role of cultural context of gender inequality in which a man's well being is seen to be more important than a woman's fitness. It is reasonable that possible cultural influences and features may play an important role in our findings.
Overall, the take-home message derived from this study is that physicians should consider the context in which sexual symptoms develop, analyzing the relationship and partner's behaviors and diseases. Resolving, or at least ameliorating, the relational background and the sexual framework might help in treating ED, although well-controlled studies on this topic are needed (Althof et al, 2005). Nonetheless, investigation, diagnosis and, eventually treatment of female sexual dysfunction should be considered in patients consulting for ED or DE raised in the contest of couple sexual dysfunction. Successful treatment of male sexual symptoms may, in this case, aid the overall sexual fitness of the couple (Fisher et al, 2005; Goldstein et al, 2005).
| Appendix |
|---|
|
|
|---|
Which diseases? Do these diseases affect the quality of your partner's life? Do these diseases make your sexual intercourse more difficult?
Saying important diseases, we mean those that affect in a considerable way the quality of the patient's life. Some of these diseases can affect sexual activity in a considerable manner; the obstacle to sexual activity has to be considered as an objective obstacle and not as a subjective one. For example, the patient may have subjective difficulties in making love with a woman affected by breast cancer and who underwent mastectomy, even if she is healthy at the moment, while the objective obstacle can be represented by the partner's advanced disease stage or by the side effects of treatment.
#8 Does your partner have more or less desire to make love than in the past?
Rank 0 when the partner's desire is unmodified or increased; 1 if desire is moderately reduced but the frequency of sexual intercourse is not reduced in a relevant manner; 2 if desire is reduced in such a way as to reduce considerably the frequency of sexual intercourse; 3 if the partner has never showed a real desire to make love. The question investigates only the partner's, and not the patient's, desire. If the frequency of sexual intercourse is reduced due to impairment of the patient's (and not the partner's) desire, rank 0. The last 3 months should be considered.
#9 Does your partner reach climax?
How often?
0 if the partner reaches climax in all occasions of intercourse; 1 if climax is reached in more than half of occasions but not always; 2 if less than half of occasions; 3 if climax has never been reached.
#10 Is your partner in menopause?
Does she have any problems due to menopause? Do these problems make sexual activity more difficult? Does your partner have vaginal dryness? Does she have pain during penetration?
If the partner is a male, or if the partner is a premenopausal woman, the score is 0. If the partner is in menopause but she has no menopause-related disturbances or she has disturbances which do not interfere with sexual intercourse (eg, flushing), the score is 1. The score is 2 when there is sporadic vaginal dryness and/or dyspareunia; the score is 3 when menopause-related symptoms are such as to make sexual intercourse impossible.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Atkins DC, Yi J, Baucom DH, Christensen A. Infidelity in couples seeking marital therapy. J Fam Psychol. 2005; 19: 470 473.[CrossRef][Medline]
Broderick GA, Foremann MM. Iatrogenic erectile dysfunction: pharmacological and surgical therapies that alter male sexual behaviour and erectile performance. In: Carson C, Kirby R, Goldstein I, eds. Textbook of Erectile Dysfunction. Oxford: Isis Medical Media Ltd; 1999: 149 168.
Corona G, Jannini EA, Maggi M. Inventories for male and female sexual dysfunctions. Int J Impot Res. 2006a; 18: 236 250.[CrossRef][Medline]
Corona G, Mannucci E, Petrone L, Fisher AD, Balercia G, De
Scisciolo G, Pizzocaro A, Giommi R, Chiarini V, Forti G, Maggi M.
Psychobiological correlates of delayed ejaculation in male patients with
sexual dysfunctions. J Androl. 2006b; 27: 453
458.
Corona G, Mannucci E, Petrone L, Giommi R, Mansani R, Fei L, Forti G, Maggi M. Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction. Int J Impot Res. 2004a; 16: 275 281.[CrossRef][Medline]
Corona G, Petrone L, Mannucci E, Jannini EA, Mansani R, Magini A, Giommi R, Forti G, Maggi M. Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. Eur Urol. 2004b; 46: 615 622.[CrossRef][Medline]
Corona G, Petrone L, Mannucci L, Ricca V, Balercia G, Giommi R, Forti G, Maggi M. The impotent couple: low desire. Int J Androl. 2005;28(Suppl 2): 4652.[Medline]
Crown S, Crisp AH. A short clinical diagnostic self-rating scale
for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.).
Br J Psychiatry. 1966; 112: 917
923.
Derogatis LR, Meyer JK, Gallant BW. Distinction between male and
female invested partners in sexual disorders. Am J
Psychiatry. 1977;134: 385
390.
Dioguardi N, Comazzi AM, Nielsen NP. Psychological profile of the spa user. Preliminary study of motivations for spa treatment. Minerva Med. 1984; 75: 2793 2798.[Medline]
Fisher WA, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Goldstein I, Bangerter K, Bandel TJ, Derogatis LR, Sand M. Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med. 2005;2: 699 708.[CrossRef][Medline]
Giommi R, Corona G, Maggi M. The therapeutic dilemma: how to use psychotherapy. Int J Androl. 2005; 28(Suppl 2): 81 85.
Goldstein I, Fisher WA, Sand M, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Bangerter K, Bandel TJ, Derogatis LR, for the Vardenafil Study Group. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial. J Sex Med. 2005; 2: 819 832.[CrossRef][Medline]
Greenstein A, Abramov L, Matzkin H, Chen J. Sexual dysfunction in women partners of men with erectile dysfunction. Int J Impot Res. 2006;18: 44 46.[CrossRef][Medline]
Jannini EA, Lenzi A. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping. World J Urol. 2005; 23: 68 75.[CrossRef][Medline]
Lau JT, Kim JH, Tsui HY. Prevalence and factors of sexual problems in Chinese males and females having sex with the same-sex partner in Hong Kong: a population-based study. Int J Impot Res. 2006; 18: 130 140.[CrossRef][Medline]
Mancini M, Bartolini M, Maggi M, Innocenti P, Villari N, Forti G. Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. Int J Androl. 2000; 23: 199 204.[CrossRef][Medline]
Master WH, Johnson VE. Human Sexual Inadequacy. London: J & A Churchill Ltd; 1970 .
Oberg K, Fugl-Meyer AR, Fugl-Meyer KS. On categorization and quantification of women's sexual dysfunctions: an epidemiological approach. Int J Impot Res. 2004; 16: 261 269.[CrossRef][Medline]
Petrone L, Mannucci E, Corona G, Bartolini M, Forti G, Giommi R, Maggi M. Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. Int J Impot Res. 2003; 15: 210 220.[CrossRef][Medline]
Potts M, Short R. Ever Since Adam and Eve: The Evolution of Human Sexuality. Cambridge: Cambridge University Press; 1999 .
Riley A, Riley E. Behavioural and clinical findings in couples where the man presents with erectile disorder: a retrospective study. Int J Clin Pract. 2000; 54: 220 224.[Medline]
Shindel A, Quayle S, Yan Y, Husain A, Naughton C. Sexual dysfunction in female partners of men who have undergone radical prostatectomy correlates with sexual dysfunction of the male partner. J Sex Med. 2005;2: 833 841.[CrossRef][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |